Sfoglia per Rivista SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES
Mostrati risultati da 1 a 7 di 7
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force
2011 Baughman, Rp; Nagai, S; Balter, M; Costabel, U; Drent, M; du Bois, R; Grutters, Jc; Judson, Ma; Lambiri, I; Lower, Ee; Muller Quernheim, J; Prasse, A; Rizzato, G; Rottoli, P; Spagnolo, Paolo; Teirstein, A.
Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosis.
2009 F., Luppi; M., Losi; D'Amico, Roberto; Lm, Fabbri; Richeldi, Luca
Increased proportion of CD8(+) T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD
2003 M., Saetta; S., Baraldo; G., Turato; Beghe', Bianca; Gl, Casoni; Cm, Bellettato; F., Rea; R., Zuin; Fabbri, Leonardo; A., Papi
Long-term management of IPF with pirfenidone - A clinical case study with 5 years follow-up
2013 Richeldi, Luca; Sgalla, Giacomo; Cerri, Stefania
Measurement of exhaled nitric oxide in healthy adults.
2007 Piero, Maestrelli; Silvia, Ferrazzoni; Annalisa, Visentin; Emanuela, Marian; Davide Dal, Borgo; Rosalba, Accordino; Fabbri, Leonardo
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role?
2005 Luppi, F; Cerri, Stefania; Richeldi, Luca
The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report
2005 Tinelli, C; De Silvestri, A; Richeldi, Luca; Oggionni, T.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force | 1-gen-2011 | Baughman, Rp; Nagai, S; Balter, M; Costabel, U; Drent, M; du Bois, R; Grutters, Jc; Judson, Ma; Lambiri, I; Lower, Ee; Muller Quernheim, J; Prasse, A; Rizzato, G; Rottoli, P; Spagnolo, Paolo; Teirstein, A. | |
Endogenous blood maximal interferon-gamma production may predict response to interferon-gamma 1beta treatment in patients with idiopathic pulmonary fibrosis. | 1-gen-2009 | F., Luppi; M., Losi; D'Amico, Roberto; Lm, Fabbri; Richeldi, Luca | |
Increased proportion of CD8(+) T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD | 1-gen-2003 | M., Saetta; S., Baraldo; G., Turato; Beghe', Bianca; Gl, Casoni; Cm, Bellettato; F., Rea; R., Zuin; Fabbri, Leonardo; A., Papi | |
Long-term management of IPF with pirfenidone - A clinical case study with 5 years follow-up | 1-gen-2013 | Richeldi, Luca; Sgalla, Giacomo; Cerri, Stefania | |
Measurement of exhaled nitric oxide in healthy adults. | 1-gen-2007 | Piero, Maestrelli; Silvia, Ferrazzoni; Annalisa, Visentin; Emanuela, Marian; Davide Dal, Borgo; Rosalba, Accordino; Fabbri, Leonardo | |
Steroid and/or other immunosuppressive therapies in idiopathic interstitial pneumonias: have they still a role? | 1-gen-2005 | Luppi, F; Cerri, Stefania; Richeldi, Luca | |
The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report | 1-gen-2005 | Tinelli, C; De Silvestri, A; Richeldi, Luca; Oggionni, T. |
Mostrati risultati da 1 a 7 di 7
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile